TY - JOUR
T1 - The Resistance Exercise in Already Active Diabetic Individuals (READI) Randomized Clinical Trial
AU - READI Trial Investigators
AU - Sigal, Ronald J.
AU - Yardley, Jane E.
AU - Perkins, Bruce A.
AU - Riddell, Michael C.
AU - Goldfield, Gary S.
AU - Donovan, Lois
AU - Malcolm, Janine
AU - Hadjiyannakis, Stasia
AU - Edwards, Alun L.
AU - Gougeon, Réjeanne
AU - Wells, George A.
AU - Pacaud, Danièle
AU - Woo, Vincent
AU - Ford, Gordon T.
AU - Coyle, Doug
AU - Phillips, Penny
AU - Doucette, Steve
AU - Khandwala, Farah
AU - Kenny, Glen P.
AU - Sargious, Peter
AU - Janzen, Laela
AU - Mitchell, Diana
AU - Richardson, Janet
AU - Gilchrist, Colleen
AU - Rouatt, Sharon
AU - Orszag, Andrej
AU - Baughan, Lynn
AU - Clearwaters, Mary Ann
AU - Ilnyckyj, Maria
AU - Pockett, Sheri
AU - Berard, Lori
AU - Hind, Krista
AU - Wein, Marta
AU - Robertson, Kimberly
AU - Phillips, Kelley
AU - Hanlon, Brittany
AU - Santilli, Antonio
AU - Potter, Dave
AU - Jarvis, Chris
AU - Jarvie, Ian
AU - Petrie, Alison
AU - Ori, Elaine
AU - Wood, Blake
AU - Despielgelaere, Marc
AU - Murphy, Ann
AU - Gillam, Melanie
AU - Zarn, Dayna
N1 - Publisher Copyright:
© The Author(s) 2022. Published by Oxford University Press on behalf of the Endocrine Society. All rights reserved.
PY - 2023/5/1
Y1 - 2023/5/1
N2 - Context: Resistance exercise training (strength training) and aerobic exercise training are both recommended for people with type 1 diabetes, but it is unknown whether adding resistance exercise provides incremental benefits in people with this condition who already perform aerobic exercise regularly. Objective: This work aimed to evaluate the incremental effect of resistance training on glycated hemoglobin A1c (HbA1c), fitness, body composition, and cardiometabolic risk factors in aerobically active people with type 1 diabetes. Methods: The Resistance Exercise in Already-active Diabetic Individuals (READI) trial (NCT00410436) was a 4-center, randomized, parallel-group trial. After a 5-week run-in period with diabetes management optimization, 131 aerobically active individuals with type 1 diabetes were randomly assigned to resistance exercise (n = 71, intervention—INT) or control (n = 60, CON) for 22 additional weeks. Both groups maintained their aerobic activities and were provided dietary counseling throughout. Exercise training was 3 times per week at community-based facilities. The primary outcome was HbA1c, and secondary outcomes included fitness (peak oxygen consumption, muscle strength), body composition (anthropometrics, dual-energy x-ray absorptiometry, computed tomography), and cardiometabolic risk markers (lipids, apolipoproteins). Assessors were blinded to group allocation. Results: There were no significant differences in HbA1c change between INT and CON. Declines in HbA1c (INT: 7.75 ± 0.10% [61.2 ± 1.1 mmol/ mol] to 7.55 ± 0.10% [59 ± 1.1 mmol/mol]; CON: 7.70 ± 0.11% [60.7 ± 1.2 mmol/mol] to 7.57 ± 0.11% [59.6 ± 1.3 mmol/mol]; intergroup difference in change −0.07 [95% CI, −0.31 to 0.18]). Waist circumference decreased more in INT than CON after 6 months (P=.02). Muscular strength increased more in INT than in CON (P<.001). There were no intergroup differences in hypoglycemia or any other variables. Conclusion: Adding resistance training did not affect glycemia, but it increased strength and reduced waist circumference, in aerobically active individuals with type 1 diabetes.
AB - Context: Resistance exercise training (strength training) and aerobic exercise training are both recommended for people with type 1 diabetes, but it is unknown whether adding resistance exercise provides incremental benefits in people with this condition who already perform aerobic exercise regularly. Objective: This work aimed to evaluate the incremental effect of resistance training on glycated hemoglobin A1c (HbA1c), fitness, body composition, and cardiometabolic risk factors in aerobically active people with type 1 diabetes. Methods: The Resistance Exercise in Already-active Diabetic Individuals (READI) trial (NCT00410436) was a 4-center, randomized, parallel-group trial. After a 5-week run-in period with diabetes management optimization, 131 aerobically active individuals with type 1 diabetes were randomly assigned to resistance exercise (n = 71, intervention—INT) or control (n = 60, CON) for 22 additional weeks. Both groups maintained their aerobic activities and were provided dietary counseling throughout. Exercise training was 3 times per week at community-based facilities. The primary outcome was HbA1c, and secondary outcomes included fitness (peak oxygen consumption, muscle strength), body composition (anthropometrics, dual-energy x-ray absorptiometry, computed tomography), and cardiometabolic risk markers (lipids, apolipoproteins). Assessors were blinded to group allocation. Results: There were no significant differences in HbA1c change between INT and CON. Declines in HbA1c (INT: 7.75 ± 0.10% [61.2 ± 1.1 mmol/ mol] to 7.55 ± 0.10% [59 ± 1.1 mmol/mol]; CON: 7.70 ± 0.11% [60.7 ± 1.2 mmol/mol] to 7.57 ± 0.11% [59.6 ± 1.3 mmol/mol]; intergroup difference in change −0.07 [95% CI, −0.31 to 0.18]). Waist circumference decreased more in INT than CON after 6 months (P=.02). Muscular strength increased more in INT than in CON (P<.001). There were no intergroup differences in hypoglycemia or any other variables. Conclusion: Adding resistance training did not affect glycemia, but it increased strength and reduced waist circumference, in aerobically active individuals with type 1 diabetes.
KW - HbA
KW - exercise training
KW - physical activity
KW - strength training
KW - type 1 diabetes
UR - http://www.scopus.com/inward/record.url?scp=85152490544&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85152490544&partnerID=8YFLogxK
U2 - 10.1210/clinem/dgac682
DO - 10.1210/clinem/dgac682
M3 - Article
C2 - 36459469
AN - SCOPUS:85152490544
SN - 0021-972X
VL - 108
SP - E63-E75
JO - Journal of Clinical Endocrinology and Metabolism
JF - Journal of Clinical Endocrinology and Metabolism
IS - 5
ER -